Covera™ Vascular Covered Stent
The Covera™ Vascular Covered Stent is part of the Bard portfolio supplied by BD, designed for haemodialysis arteriovenous (AV) access patients. BD describes it as a covered stent platform designed to balance the flexibility and strength required to address challenging lesions, from the terminal cephalic arch to the basilic swingpoint segments to the AV graft venous anastomosis. According to BD, the platform builds on proven technologies from the category leader in AV access, and delivered effective results in two separate clinical trials — one for patients dialysing with AV grafts and one for patients dialysing with AV fistulas. BD details several design elements. The stent is fully encapsulated between two ePTFE layers, which BD states is designed to resist neointimal hyperplasia in the treatment area, and has a flexible base stent architecture with helical struts and angled bridges engineered for flexion, compression and torsion. BD describes contoured edges designed to optimise wall apposition and promote laminar flow, carbon impregnation throughout the lumen to help reduce early stage platelet adhesion, and tantalum markers for enhanced visibility under fluoroscopy. Straight and flared configurations allow adaptation to the outflow and inflow vessel diameters, and an intuitive triaxial thumbwheel delivery system with two speed options is described by BD as facilitating accurate placement control. For interventional nephrology and vascular teams in Azerbaijan, the relevant interest is a covered stent tailored to AV access anatomy. Azmed Devices provides manufacturer documentation, registration status, tender support and supply coordination for BD peripheral vascular products. Detailed specifications and available configurations are available on request.
Sizes & Specifications
- Specifications
- Available on request
Manufacturer: C. R. Bard, Inc. (a BD company) · Reference source: bd.com
Product Features
Design characteristics as published by Bard.
Designed for AV access
BD describes a covered stent tailored for AV patients, addressing lesions from the cephalic arch to the graft venous anastomosis.
Dual ePTFE encapsulation
BD states full encapsulation between two ePTFE layers is designed to resist neointimal hyperplasia in the treatment area.
Flexible stent architecture
BD describes helical struts and angled bridges engineered for flexion, compression and torsion.
Carbon impregnation
BD states the lumen is carbon impregnated to help reduce early stage platelet adhesion.
Thumbwheel delivery
BD describes a triaxial delivery system with dual-speed thumbwheels for accurate placement control.
Documentation
Official IFU, straight and flared configurations and full specifications are available on request through Azmed Devices.
Product Identification & Specifications
Reference identifiers for procurement, registration and tender documentation.
| Manufacturer | C. R. Bard, Inc. (a BD company) |
|---|---|
| Brand | Bard |
| Product Family | Peripheral Vascular |
| Country Availability | Azerbaijan |
Clinical Applications
The Covera™ Vascular Covered Stent is a eptfe-encapsulated covered stent for av access in the Peripheral Vascular family from C. R. Bard, Inc. (a BD company), used by interventional specialists in procedures where a eptfe-encapsulated covered stent for av access of this class is indicated.
For the complete indications for use, contraindications and instructions for use (IFU), request the official Bard documentation through our clinical team. Azmed Devices supplies the Covera™ Vascular Covered Stent to hospitals and clinics across Azerbaijan.
Downloads & Documentation
Instructions for use (IFU), technical datasheets and clinical literature for the Covera™ Vascular Covered Stent are available on request from our clinical team.
Request DocumentationFrequently Asked Questions
- Which patients is the Covera Vascular Covered Stent designed for?
- BD describes it as a covered stent tailor-made for AV access patients, designed to address challenging lesions from the terminal cephalic arch to the basilic swingpoint segments and the AV graft venous anastomosis.
- What does BD say about its clinical results?
- BD states the Covera™ stent delivered effective results in two separate clinical trials — one for patients dialysing with AV grafts and one for patients dialysing with AV fistulas.
- How can our hospital order Covera Vascular Covered Stent in Azerbaijan?
- Contact Azmed Devices at info@azmeddevices.com. We provide manufacturer documentation, registration status and tender support, and coordinate supply for BD technologies.
